SYNTAXBIO
SyntaxBio develops CRISPR/Cas9-based, genetic programming platform that converts cells into biological computers using DNA-based instructions that read like lines of code. SyntaxBio's platform can program cells without the need for consistent external intervention.
SYNTAXBIO
Industry:
Biotechnology Medical Product Research
Address:
Chicago, Illinois, United States
Country:
United States
Status:
Active